Get a Sample
Schedule a Meeting
Get a Sample
Table Of Content
July 2025
The global ophthalmic devices market size accounted for USD 48.36 billion in 2025 and is projected to surpass around USD 73.74 billion by 2034, representing a healthy CAGR of 4.80% between 2025 and 2034. The North America ophthalmic devices market size surpassed USD 19.84 billion in 2024 and is expanding at a CAGR of 4.92% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global ophthalmic devices market size was estimated at USD 46.14 billion in 2024 and is anticipated to reach around USD 73.74 billion by 2034, expanding at a CAGR of 4.80% between 2025 and 2034.
AI is getting into even ophthalmic setups, ever so fine-tuning the accuracy and efficiency of eye care and making it more accessible. These advanced algorithms make the analysis of retinal images and OCT scans so delicate for early detection of diabetic retinopathy and glaucoma that reduced variability in diagnosis and an improvement in treatment outcomes are achieved. Through increased precision of intraocular lens calculations and real-time surgical evaluation, cataract surgery is precisely optimized by AI. Personalized design of eyewear decreases discomfort and enhances visual comfort. Predictive diagnostics allow for tracking the evolution of a disease and establishing recommendations for preventive treatment. AI is also supporting teleophthalmology, thereby increasing the reach in underdeveloped areas, whereas the autonomous interpretation of images helps to reduce the administrative responsibilities of practitioners. These assist in overcoming problems throughout restricted ophthalmic specialists and hence faster AI diagnosis would have more quality within prevention ophthalmic bays along with corrective ophthalmic practices.
The U.S. ophthalmic devices market size was valued at USD 13.89 billion in 2024 and is expected to be worth around USD 22.61 billion by 2034, growing at a CAGR of 4.99% from 2025 to 2034.
North America had the largest market share till the last year as an increasing geriatric population and prevailing eye conditions in the North American region the market for ophthalmic devices is expected you grow during the forecast period. Unhealthy lifestyles are resulting in diabetic retinopathy and other stress related complaints these are the reasons why the industry for ophthalmic devices is growing. The demand for ophthalmic devices is expected to grow in the North American region due to the various reimbursement models incorporated by the insurance providers and the regulatory framework aimed at the patient safety.
The Asia Pacific market is also expected to have a good growth during the forecast. As an increasing demand for eye care and health care infrastructure is improving in this region prevailing eye disorders like glaucoma and the awareness of patient towards the surgeries related to it are helping in the growth of the market. The availability and the increased awareness regarding the advanced corrective vision treatments in the developing nations shall be a major driving factor during the forecast.
Europe is observed to grow at a considerable growth rate in the upcoming period, fueled by an aging demographic and the growing incidence of eye conditions such as glaucoma, cataracts, and diabetic retinopathy. Nations including Germany, France, and the UK are committing resources to advanced diagnostic and surgical technologies to improve eye care services. The region's robust healthcare infrastructure and focus on early disease diagnosis are leading to a greater uptake of ophthalmic devices. Furthermore, favorable government initiatives and investment in healthcare innovation are driving market growth. Together, these elements firmly establish Europe as a significant player in the global ophthalmic devices sector.
Germany
Germany distinguishes itself in the European ophthalmic devices market with its sophisticated medical technology industry and comprehensive healthcare framework. The nation is experiencing a rising demand for inventive eye care solutions, including diagnostic imaging technology and surgical tools. German firms are pioneering the development of state-of-the-art ophthalmic technologies, backed by considerable funding for research and development. This commitment to innovation and quality care reinforces Germany's dominance in the European ophthalmic devices arena.
Increasing demand for quality eye care and increasing demand for surgeries for vision disorders will help in the growth of the global ophthalmic devices market. Ophthalmic devices are devices that are used in improving vision disorders or which can help in aiding vision. Various market players are focusing on strengthening their research and development teams for the development of devices in the treatment of vision errors developments in this field would provide a huge opportunity to capture a large cost customer base and accelerate the growth of the ophthalmic devices market.
The pandemic had a negative impact on the ophthalmic devices market due to an increase in the dry eye diseases the eye drops were sold mold during the pandemic but major surgeries or sales of contact lenses had come down drastically.
Due to an increase in cataract surgeries and implants the surgical segment is expected to grow and increasing demand for eye surgeries is expected to help in the growth of the market. As there is an increase in the demand for contact lenses and innovative equipments these devices shall lead the market. Micro invasive glaucoma surgical implants are the fastest growing market treatment. Due to many disorders related to the eyes like the diabetic retinopathy, cataracts, age related degeneration and all the other prevailing ophthalmic disorders shall lead to a growth of the market.
Rapid increase in the eye disease is due to many lifestyle changes is expected to fuel the demand for surgical and vision care devices increased per capita income and high disposable income, favorable reimbursement policies, easily available ophthalmic procedures are increasing the surgical procedures and therefore the demand for ophthalmic devices market is growing.
Increased screen time during the lockdowns in pandemic are associated with the various eye disorders and it shall drive the demand for eye examinations. Increased initiatives by the government to create an awareness regarding the visual disorders or impairments shall further drive the market.
Increase in Minimally Invasive Procedures: There is a growing demand for minimally invasive ophthalmic surgeries, resulting in a rise in the use of advanced laser technologies and femtosecond systems for cataract and refractive procedures globally.
Incorporation of Artificial Intelligence (AI): Ophthalmic diagnostics are increasingly integrating AI to improve precision in identifying conditions such as glaucoma and diabetic retinopathy, facilitating early diagnosis and tailored treatment strategies in both clinical and teleophthalmology settings.
Surge in Home-Based Eye Care Devices: The market is experiencing an increase in portable, home-based ophthalmic monitoring devices that enable patients to manage their eye health remotely, lessening the need for frequent clinic visits and enhancing accessibility.
| Report Coverage | Details |
| Market Size in 2024 | USD 46.14 Billion |
| Market Size in 2025 | USD 48.36 billion |
| Market Size by 2034 | USD 73.74 Billion |
| Growth Rate from 2025 to 2034 | CAGR of 4.80% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Product, End User, and Geography |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
R&D in ophthalmology covers all steps of conceiving, testing, and marketing new and improved tools to diagnose, monitor, and treat eye disorders.
Key players: Alcon, Johnson & Johnson Vision Care
Clinical trials for ophthalmic devices are set up as human studies to demonstrate the safety and efficacy of the new device for an eye condition so that it can be marketed.
Key players: U.S. Food and Drug Administration (FDA)
Formulation and final dosage preparations for ophthalmic devices, such as eye drops, ointments, and inserts, require development and several stages of finalization in order to be deemed safe, efficacious, and comfortable for the patient.
Key players: Novartis AG, Santen Pharmaceutical Co. Ltd.
Packaging and serialization for ophthalmic devices cover all elements of regulatory applicability and specific methods that aim to ensure patient safety, maintain product sterility, and provide traceability throughout the supply chain.
Patient support and services for ophthalmic devices refer to a broad range of programs that help patients obtain, utilize, and benefit from eye-related medical products.
Ophthalmic devices are segmented into vision care and surgical devices. The vision care segment has the largest market share and is expected to grow well in the forthcoming years as many patients with the eye disorders using eyeglasses are shifting to contact lenses. Advances in the contact lenses are anticipated to create a more demand for the product in the market. About 45 million people in US use contact lenses and this shall increase in the coming years leading to a growth in the market. An increase in intraocular lens and the number of cataract and retinal surgeries the ophthalmic devices market shall see a growth in the forecast.
The cataract segment dominated the market in the recent years and it is expected to see a significant growth during the forecast. Due to higher adoption of these devices and increasing cataract surgeries is driving the market. The leading cause of blindness is scattered has a demand for cataract surgeries. 51% of blindness cases across the world are due to cataract the other segment that will show fast growth during the forecast period is the refractor disorder segment. About 2 billion people have near or far-distance vision impairment in order to treat all of these disorders which are related to the eyes and correct the refractive errors ophthalmic devices has a great demand across the globe. As an increasing population major market players are focusing on meeting the requirements of the rising patient demands. Major players are also introducing advanced ophthalmic diagnosis and treatment devices across the globe.
On the basis of the end user, the hospital and eye clinic segment had the largest market share in the ophthalmic devices market and it is expected to grow during the forecast period. There is an increasing adoption of ophthalmic devices in the hospitals which provide effective and low-cost treatment. The adoption of ophthalmic devices in the clinic is also growing as an increasing number of mergers and acquisitions in major and minor ophthalmic clinics and hospitals is there. An increasing number of mergers and acquisitions in various ophthalmic clinics and hospital the demand for ophthalmic devices is expected to grow during the forecast.
Many eye clinics are coming up with separate diagnostic departments which help in boosting the market of ophthalmic devices. The cost-effective eye treatment across the developing and the developed nations is expected to drive the market growth during the forecast period. The demand for ophthalmic devices is expected to grow in the academic and research laboratories segment.
By Product
By End User
By Geography
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
July 2025
January 2025
October 2024
July 2025